Search research articles
Contact Us
Filters
Showing results (321-330 of 393) with videos related to
Page
of 40
Sort By:
Academic Radiology
|
July 12, 2025
Corrigendum to 'Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study' [Acad Radiol 32/2 (2025) 1100-1107]
Edward W Johnston, Jessica M Winfield, Amani Arthur, et al.
Annals of Surgery
|
December 19, 2019
Oncological Outcome After Diagnostic Biopsies in Gastrointestinal Stromal Tumors: A Retrospective Cohort Study
Winan J van Houdt, Nikki S IJzerman, Anne Marjolein Schrijver, et al.
Cancer
|
April 30, 2019
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas
Robin L Jones, Sant P Chawla, Steven Attia, et al.
Academic Radiology
|
November 26, 2024
Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study
Edward W Johnston, Jessica M Winfield, Amani Arthur, et al.
Nature Communications
|
March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Cancers
|
March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
The Oncologist
|
January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
Suzanne George, Robin L Jones, Sebastian Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
The Oncologist
|
July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
John R Zalcberg, Michael C Heinrich, Suzanne George, et al.
Future Oncology (London, England)
|
April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma
Mrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 393) with videos related to
Sort By:
Page
of 40
Academic Radiology
|
July 12, 2025
Corrigendum to 'Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study' [Acad Radiol 32/2 (2025) 1100-1107]
Edward W Johnston, Jessica M Winfield, Amani Arthur, et al.
Annals of Surgery
|
December 19, 2019
Oncological Outcome After Diagnostic Biopsies in Gastrointestinal Stromal Tumors: A Retrospective Cohort Study
Winan J van Houdt, Nikki S IJzerman, Anne Marjolein Schrijver, et al.
Cancer
|
April 30, 2019
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas
Robin L Jones, Sant P Chawla, Steven Attia, et al.
Academic Radiology
|
November 26, 2024
Robotic MRI/CT Guided Multiregional 'smart' Biopsy for Characterization of Tumor Heterogeneity: A Prospective Development Study
Edward W Johnston, Jessica M Winfield, Amani Arthur, et al.
Nature Communications
|
March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Cancers
|
March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
The Oncologist
|
January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
Suzanne George, Robin L Jones, Sebastian Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
The Oncologist
|
July 27, 2021
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
John R Zalcberg, Michael C Heinrich, Suzanne George, et al.
Future Oncology (London, England)
|
April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma
Mrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Page
of 40